Tetanus toxoid vaccine market to reach $7.37 billion by 2030 at 6.2% CAGR, driven by rising rate of preterm births increasing neonatal infection risk.
Read More
Testosterone replacement therapy market to reach $2.57 billion by 2030 at 4.0% CAGR, driven by rising testosterone deficiency among aging men.
Read More
Testosterone cypionate api market to reach $6.38 billion by 2030 at 10.9% CAGR, driven by growing frequency of hypogonadism and rising geriatric male population.
Read More
Testosterone booster market to reach $7.83 billion by 2030 at 6.3% CAGR, driven by growing awareness about health and fitness among men.
Read More
Tenosynovitis drugs market to reach $1.84 billion by 2030 at 7.6% CAGR, driven by increasing incidence of sports injuries and rising healthcare expenditure.
Read More
Tenofovir disoproxil market to reach $4.86 billion by 2030 at 5.3% CAGR, driven by growing prevalence of hepatitis b and rising healthcare expenditure.
Read More
Temperature-stable messenger ribonucleic acid vial market to reach $3.77 billion by 2030 at 13.3% CAGR, driven by increasing participation in global vaccination programs.
Read More
Tcr therapy market to reach $1.15 billion by 2030 at 34.8% CAGR, driven by increasing incidence of cancer requiring advanced immunotherapies.
Read More
Tazarotene market to reach $6.44 billion by 2030 at 7.1% CAGR, driven by increasing occurrence of skin diseases such as acne and psoriasis.
Read More
Targeted alpha-therapy market to reach $2.25 billion by 2030 at 17.0% CAGR, driven by growing focus on precision medicine in oncology care.
Read More